Target Name: SPATA31D3
NCBI ID: G389762
Review Report on SPATA31D3 Target / Biomarker Content of Review Report on SPATA31D3 Target / Biomarker
SPATA31D3
Other Name(s): FAM75-like protein FLJ44082 | Protein FAM75D3 | Spermatogenesis-associated protein 31D3 | family with sequence similarity 75, member D3 | Putative FAM75-like protein FLJ44082 | S31D3_HUMAN | Family with sequence similarity 75, member D3 | SPATA31 subfamily D member 3 | putative protein FAM75D3 | FAM75D3 | Putative protein FAM75D3 | putative spermatogenesis-associated protein 31D3

SPATA31D3: A Potential Drug Target Or Biomarker

SPATA31D3 (FAM75-like protein FLJ44082) is a protein that has been identified as a potential drug target or biomarker. The protein is found in various tissues throughout the body and is involved in the regulation of cellular processes that are important for proper cell growth and function.

The protein is characterized by its unique structure and sequence. It is made up of 214 amino acids and has a calculated molecular weight of 23.9 kDa. The protein is found in the cytoplasm of various cell types and is expressed in high levels in tissues such as the brain, heart, and liver.

One of the key features of SPATA31D3 is its ability to interact with other proteins. It has been shown to interact with a variety of proteins, including the transcription factor p53 and the protein heat shock protein HSP70. These interactions may play a role in the regulation of cellular processes that are important for proper cell growth and function.

SPATA31D3 is also known for its role in the regulation of cellular apoptosis, which is the process by which cells die when they have reached their lifespan. The protein has been shown to play a positive role in the regulation of apoptosis, which may be important for the development and progression of certain diseases.

In addition to its role in apoptosis, SPATA31D3 has also been shown to be involved in the regulation of cellular signaling processes. It has been shown to interact with the protein kinase kinase A1 (PKA), which is involved in the regulation of cellular signaling processes. . This interaction may play a role in the regulation of cellular processes that are important for proper cell growth and function.

SPATA31D3 has also been shown to have potential as a drug target. Its unique structure and sequence, as well as its ability to interact with other proteins, make it a promising target for drug development. Additionally, its role in the regulation of apoptosis and cellular signaling processes may make it an attractive target for the development of new therapeutic approaches for a variety of diseases.

In conclusion, SPATA31D3 is a protein that has been identified as a potential drug target or biomarker. Its unique structure and sequence, as well as its ability to interact with other proteins, make it a promising target for drug development. Further research is needed to fully understand the role of SPATA31D3 in cellular processes and its potential as a drug target.

Protein Name: SPATA31 Subfamily D Member 3

Functions: May play a role in spermatogenesis

The "SPATA31D3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPATA31D3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SPATA31E1 | SPATA32 | SPATA33 | SPATA4 | SPATA41 | SPATA42 | SPATA45 | SPATA46 | SPATA48 | SPATA5 | SPATA5L1 | SPATA6 | SPATA6L | SPATA7 | SPATA8 | SPATA8-AS1 | SPATA9 | SPATC1 | SPATC1L | SPATS1 | SPATS2 | SPATS2L | SPC24 | SPC25 | SPCS1 | SPCS2 | SPCS2P4 | SPCS3 | SPDEF | SPDL1 | SPDYA | SPDYC | SPDYE1 | SPDYE18 | SPDYE2 | SPDYE21 | SPDYE2B | SPDYE3 | SPDYE4 | SPDYE5 | SPDYE6 | SPDYE7P | SPDYE8 | SPDYE9 | SPECC1 | SPECC1L | SPECC1L-ADORA2A | SPEF1 | SPEF2 | SPEG | SPEM1 | SPEM2 | SPEN | SPEN-AS1 | SPESP1 | SPG11 | SPG21 | SPG7 | SPHAR | Sphingolipid delta(4)-desaturase | Sphingomyelin phosphodiesterase | Sphingomyelin synthase | Sphingosine kinase | SPHK1 | SPHK2 | SPHKAP | SPI1 | SPIB | SPIC | SPICE1 | SPIDR | SPIN1 | SPIN2A | SPIN2B | SPIN3 | SPIN4 | SPINDOC | SPINK1 | SPINK13 | SPINK14 | SPINK2 | SPINK4 | SPINK5 | SPINK6 | SPINK7 | SPINK8 | SPINK9 | SPINT1 | SPINT2 | SPINT3 | SPINT4 | SPINT5P | SPIRE1 | SPIRE2 | Spliceosomal complex | Spliceosome C complex | Spliceosome Complex | Splicing factor 3A protein complex | Splicing factor 3B protein complex | SPN